Viewing StudyNCT03681951



Ignite Creation Date: 2024-05-06 @ 12:09 PM
Last Modification Date: 2024-10-26 @ 12:54 PM
Study NCT ID: NCT03681951
Status: TERMINATED
Last Update Posted: 2020-07-31
First Post: 2018-09-10

Brief Title: First-time-in-human FTIH Study of GSK3145095 Alone and in Combination With Other Anticancer Agents in Adults With Advanced Solid Tumors
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Conditions & Keywords Data

Conditions:
Name
Neoplasms Pancreatic
Keywords:
Name View
Innate immunity View
Anticancer Agents View
FTIH View
Pembrolizumab View
Rip1K View
GSK3145095 View
Dose Escalation View
Immunotherapy resistance View
Dose Expansion View
RECIST 11 View
Advanced solid tumors View